Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment
about
CD44 in rheumatoid arthritisLeukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory diseaseHyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarizationNatalizumab and the role of alpha 4-integrin antagonism in the treatment of multiple sclerosisThe adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activationCC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitisCD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis.Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER.Negative regulation of epithelium-neutrophil interactions via activation of CD44.CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis.RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy.Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.Short day lengths augment stress-induced leukocyte trafficking and stress-induced enhancement of skin immune function.Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS.The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion.Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.Overexpression of CD44 in neural precursor cells improves trans-endothelial migration and facilitates their invasion of perivascular tissues in vivo.A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor.Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in miceEarly treatment with anti-VLA-4 mAb can prevent the infiltration and/or development of pathogenic CD11b+CD4+ T cells in the CNS during progressive EAE.4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.CD44 mobilization in allogeneic dendritic cell-T cell immunological synapse plays a key role in T cell activationAnti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice.beta2-integrins in demyelinating disease: not adhering to the paradigm.Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).Cell therapy for multiple sclerosis.Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitisExpression of interleukin-15 in mouse and human atherosclerotic lesions.Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells.Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunityExpression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.Pineal-dependent and -independent effects of photoperiod on immune function in Siberian hamsters (Phodopus sungorus).Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis.Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab.Phenotype of Antigen Unexperienced TH Cells in the Inflamed Central Nervous System in Experimental Autoimmune Encephalomyelitis.Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus.
P2860
Q24804352-E6838670-565B-439D-B87D-7A413EF2A513Q26822941-986C2287-8C1D-4256-8BE2-132037F5A2E6Q27316627-570C577F-74A8-4AC7-AA39-8F0289ABA9DCQ28277470-5F9EB5B0-5A04-4203-A9FC-F322A59FC27EQ28360727-540D1A65-D668-4644-B0C1-B3AA9F3A6278Q28587371-2D7AAFAA-E3EC-4564-88BD-4F6CF2CDEBC0Q30484967-E9460D3E-370A-45B6-A9F0-7BCE9340D6F9Q30655322-E1D96860-5EE1-4398-B0D5-8B510BEB4608Q30987183-11E03A3C-4970-475C-A14E-9040A45133CCQ31919261-975B29CB-90F4-4FFA-A224-70A63596E1D0Q33408519-9C0C8A95-45DE-431D-B3F0-F8E0774FCE39Q33582923-8314F435-0E7E-4625-8F3B-84A10F2D67A7Q33758969-8B0C4578-18B5-4EBA-8008-AE8E0E2E15D6Q34021722-3CE2AFFA-2739-4787-8E50-87B8CC1F9168Q34044654-AA89F62D-FBBD-491E-AF1D-143327E4201FQ34075924-54575302-C4B2-41F4-8547-EC3BDD10360BQ34238869-DE5CA3E2-EE23-474A-9C1B-A32D109D58C5Q34612105-04494971-37E4-48D3-85BA-5298D5B408EDQ34912686-74FBB997-7570-4AC9-A5FA-AEC9D9A099BBQ35036755-D8836813-19D8-4A21-8DB7-3D943EB8DF7DQ35181321-111C36C4-C0CE-4382-983E-CBB44E59EF13Q35206080-DE935DBB-72AF-44B8-91F3-0E2D7CDE9752Q35227673-DAB7F6A5-6112-4F6C-BDAB-1F1300CF4417Q35360350-82234295-58BA-47CD-871D-8C71CDF144D1Q35539301-4E584AB4-7E60-4C29-8F86-236555A3A442Q35589934-DD2CFD5A-123F-4DAD-9899-BD951B63013AQ35648117-111296F9-7319-4B6D-BE8B-6E49372E136FQ35689857-346EF37E-96A7-4EB7-810C-4B5CF53CA094Q35747016-4DE1E942-A0B0-425A-ADC1-96D546217A9EQ35849305-DD924E2F-0512-4DB0-8311-0C59A134B96DQ35855614-4D0C6749-69B5-4E64-9C06-AE5159F6FD6BQ35888664-EFEB9799-86F9-49AE-9EDD-7D15AA659605Q35889265-E7E09A2A-8BD7-4132-B90F-0DCD36AD5F18Q35935710-598D6F5E-3B48-49EA-AF2E-99F1EB508BB8Q35936538-D4CD38FA-D2FA-4B76-93C7-772C59099248Q36016746-89E9E5C5-FDC5-41A3-9D84-B8B261508A54Q36055389-03C38C5D-62EE-4A1E-8FCA-918C2D167082Q36148448-B0380520-BED8-4421-9B91-5B6A37D0B4EEQ36189003-F356B820-6E01-4D2A-A847-562BA55396FCQ36228518-6CAD4178-09C3-46DB-8D01-30C64E58649F
P2860
Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Antibodies to CD44 and integri ...... econdary leukocyte recruitment
@ast
Antibodies to CD44 and integri ...... econdary leukocyte recruitment
@en
type
label
Antibodies to CD44 and integri ...... econdary leukocyte recruitment
@ast
Antibodies to CD44 and integri ...... econdary leukocyte recruitment
@en
prefLabel
Antibodies to CD44 and integri ...... econdary leukocyte recruitment
@ast
Antibodies to CD44 and integri ...... econdary leukocyte recruitment
@en
P2093
P2860
P356
P1476
Antibodies to CD44 and integri ...... econdary leukocyte recruitment
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.12.6896
P407
P577
1999-06-01T00:00:00Z